Related Experiment Video
Updated: May 25, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
IKK-β mediates chemoresistance by sequestering FOXO3; a critical factor for cell survival and death
Tugsan Tezil1, Cagri Bodur, Ozgur Kutuk
1Sabanci University, Biological Sciences and Bioengineering Program, 34956, Tuzla, Istanbul, Turkey. teziltugsan@su.sabanciuniv.edu
Abstract:
Chemotherapeutic drugs proved only 50% successful in breast cancer because of cell type-dependent resistance mechanisms. FOXO3 is known to be involved in the regulation of several cell death-related genes; however, the extent of FOXO3 regulation in chemoresistance is still not fully understood. Here, we show that FOXO3 critically mediates cisplatin chemosensitivity of MCF-7 breast cancer cells which express higher levels of FOXO3 compared to resistant MDA-MB-231 cells. Administration of cisplatin induces apoptosis in MCF-7 cells in a FOXO3-dependent manner as indicated by RNA interference. On the other hand, IKK-β (IκB kinase) appears to inhibit FOXO3 action after cisplatin treatment and promotes chemoresistance in MDA-MB-231 cells. IKK-β directly interacts and sequesters FOXO3 in the cytosol preventing its nuclear localization. Moreover, cisplatin treatment induces autophagosome formation through LC-3 conversion while inhibiting the cleavage of caspase 9 and caspase 3 in MDA-MB-231 cells manipulated to overexpress FOXO3. In brief, our findings demonstrate that in addition to cellular level of active FOXO3, cisplatin chemoresistance is also regulated by IKK-β sequestration of FOXO3 in cytosol.
Insights
FOXO3 enhances cisplatin sensitivity in breast cancer cells. Inhibitor IKK-beta blocks FOXO3, promoting chemoresistance by preventing nuclear localization and apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Chemotherapy resistance in breast cancer is a significant clinical challenge, often linked to cell-type-specific mechanisms.
- The transcription factor FOXO3 regulates genes involved in cell death, but its precise role in chemoresistance remains unclear.
Purpose of the Study:
- To investigate the role of FOXO3 in mediating cisplatin chemosensitivity in breast cancer.
- To elucidate the mechanism by which IKK-beta influences FOXO3 activity and chemoresistance.
Main Methods:
- Utilized MCF-7 (high FOXO3) and MDA-MB-231 (low FOXO3) breast cancer cell lines.
- Employed RNA interference to assess FOXO3-dependent apoptosis induction by cisplatin.
- Investigated the interaction between IKK-beta and FOXO3 using cisplatin treatment and overexpression models.
Main Results:
- FOXO3 critically mediates cisplatin-induced apoptosis in MCF-7 cells.
- IKK-beta inhibits FOXO3 nuclear localization and function in MDA-MB-231 cells, promoting chemoresistance.
- Cisplatin treatment in FOXO3-overexpressing MDA-MB-231 cells led to autophagosome formation and inhibited caspase cleavage.
Conclusions:
- FOXO3 levels and activity are crucial determinants of cisplatin chemosensitivity in breast cancer.
- IKK-beta promotes chemoresistance by sequestering FOXO3 in the cytosol, hindering its pro-apoptotic function.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Regulation of Angiogenesis and Blood Supply
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
